Press-release for stocks publishing date 2022 - 11

Prices are updated after-hours

publishing date : 2022 - 11 - 07 tags : Therapeutics

save search

Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-07 (Crawled : 14:25) - ir.agiletherapeutics.com
AGRX | $0.394 3.68% 0.0% 16K

Health Technology

| -97.55% | O: -9.62% H: 2.29% C: -11.38%
therapeutics financial update results

Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter Financial Results on November 14, 2022
Published: 2022-11-07 (Crawled : 20:00) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M

Health Technology

| 49.16% | O: 1.43% H: 3.94% C: 1.09%
therapeutics financial update results

Allarity Therapeutics Announces Adjournment of 2022 Annual Meeting of Stockholders
Published: 2022-11-07 (Crawled : 00:00) - globenewswire.com
ALLR | $1.42 2.16% 3.14% 620K

n/a

| -99.82% | O: 0.0% H: 0.0% C: -10.35%
meeting therapeutics

Orchard Therapeutics to Webcast Conference Call of Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 19:00) - biospace.com/
ORTX | $16.7 0.0% 370K

Health Technology

| 264.69% | O: -4.58% H: 5.7% C: 2.46%
conference therapeutics financial results

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 19:00) - biospace.com/
MRSN | $3.15 -3.08% -2.85% 1.6M

Health Technology

| -58.22% | O: -4.51% H: 4.58% C: -7.78%
therapeutics financial update results

Incyte And Mirati Therapeutics Enter Into Clinical Trial Collaboration and Supply Agreement to Evaluate INCB99280 and Adagrasib in Patients with KRASG12C-Mutated Solid Tumors
Published: 2022-11-07 (Crawled : 18:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0

Health Technology

| -6.84% | O: 0.79% H: 0.0% C: -5.85%
INCY | $51.92 -0.82% -0.83% 1.8M

Health Technology

| -32.83% | O: 0.25% H: 0.46% C: -2.05%
incb9928 collaboration trial therapeutics tumors agreement

Amicus Therapeutics Provides EU Regulatory Update for AT-GAA
Published: 2022-11-07 (Crawled : 18:00) - globenewswire.com
FOLD F | $10.82 1.98% 2.03% 4.6M

Health Technology

| 7.02% | O: -6.92% H: 11.16% C: 9.56%
therapeutics

The global digital therapeutics market is projected to reach USD 17.7 billion by 2027 from USD 4.5 billion in 2022, at a CAGR of 31.6%
Published: 2022-11-07 (Crawled : 15:00) - prnewswire.com
TDOC S | $13.3 2.47% 0.68% 3.3M

Health Services

| -51.25% | O: 0.84% H: 1.56% C: -1.27%
global therapeutics market

Endonovo Therapeutics Issues Corporate Update
Published: 2022-11-07 (Crawled : 14:20) - globenewswire.com
ENDV | $0.0028 158.07% 74K

Professional, Scientific, and T...

| -60.0% | O: -3.75% H: 0.0% C: 0.0%
therapeutics update

Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022
Published: 2022-11-07 (Crawled : 13:20) - biospace.com/
BTTX | $0.0061 -1.61% -65.02% 300K

| -99.31% | O: 0.01% H: 2.97% C: -0.01%
therapeutics financial update results

Akero Therapeutics to Present Late-Breaking Oral and Poster presentations on EFX Today at AASLD’s The Liver Meeting® 2022Phase 2b HARMONY study presentation selected for inclusion in the Best of the Liver meeting in the NASH/NAFLD category
Published: 2022-11-07 (Crawled : 13:20) - biospace.com/
AKRO | $20.79 0.15% 0.14% 710K

Health Technology

| -45.97% | O: 2.39% H: 2.39% C: -3.12%
meeting liver therapeutics presentation today study

Spero Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
Published: 2022-11-07 (Crawled : 13:20) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K

Health Technology

| -25.4% | O: 1.59% H: 2.34% C: 1.04%
report therapeutics financial update results

Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
RPTX 4 | $3.26 3.49% 2.48% 110K

Health Technology

| -77.3% | O: 0.14% H: 0.0% C: -1.18%
therapeutics

Akero Therapeutics to Present Late-Breaking Oral and Poster presentations on EFX Today at AASLD’s The Liver Meeting® 2022
Published: 2022-11-07 (Crawled : 13:00) - ir.akerotx.com
AKRO | $20.79 0.15% 0.14% 710K

Health Technology

| -45.97% | O: 2.39% H: 2.39% C: -3.12%
meeting liver therapeutics today

Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
FOLD F | $10.82 1.98% 2.03% 4.6M

Health Technology

| 7.02% | O: -6.92% H: 11.16% C: 9.56%
therapeutics financial results

Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
AXSM | $71.1 4.71% 4.58% 500K

Health Technology

| 24.54% | O: -4.94% H: 8.4% C: 4.7%
therapeutics financial update results

Entrada Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
TRDA | $13.1 7.82% 6.36% 120K

Professional, Scientific, and T...

| -40.59% | O: -0.23% H: 0.0% C: -9.82%
therapeutics financial results

F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
Published: 2022-11-07 (Crawled : 13:00) - globenewswire.com
FSTX | $7.12 0.0% 0

Health Technology

| 39.37% | O: 0.88% H: 0.0% C: -5.44%
fs118 research trial therapeutics cancer publication phase 1

Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Published: 2022-11-07 (Crawled : 13:00) - globenewswire.com
RLAY | $5.95 -0.17% -0.34% 1.1M

Health Technology